New York Blood Center Enterprises – FDA 483, Oct 27, 2023
An FDA inspection of New York Blood Center Enterprises in Westbury, NY, revealed significant deficiencies in record-keeping, adherence to standard operating procedures, and data integrity. The firm failed to maintain adequate records for donor sample shipping and plasma processing, and did not consistently follow SOPs for blood product handling, visual inspection, and deviation management. Additionally, issues were noted with electronic data system record maintenance and the proper use of supplies and reagents according to manufacturer instructions.
ID · 6374025e-491d-4250-aeb6-7b4b9c91644a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.